Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on August 12, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES

Closed
NOI-NIAID-24-2229841Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
Joliet Job Corps-Request for Quote Asbestos Testing & Abatement
Solicitation # Joliet JCC Asbestos Testing & Abatement
Management & Training Corporation is seeking quotes for a fee-for-service subcontracting opportunity to provide asbestos testing and abatement services at the Joliet Job Corps in Joliet, Illinois. The scope of work includes sampling and laboratory analysis of ceiling tiles in the Administration Academic Building and Welcome Center, as well as testing and potential removal of asbestos-containing material from floor tiles in the Gymnasium, Warehouse, and Warehouse Storage Area, totaling approximately 4,200 square feet if confirmed. All work must be performed by licensed professionals using accredited laboratories and must comply with federal, State of Illinois, OSHA, and EPA regulations. Key deliverables include a sampling plan, waste shipment records, disposal manifests, and a final project completion report. This solicitation is open to various small business set-asides, including VOSB, SDVOSB, WOSB, and HUBZone small businesses, under NAICS code 541380. Bidders must submit a bid sheet, a completed supplier packet containing a W-9 and self-certification, proof of insurance, and three references for similar projects by October 21, 2026, at 3:00 PM CT. Award will be based on best value as determined by MTC. The contract is subject to Service Contract Labor Standards, specifically Wage Determination No. 2015-5019 Rev. 31, and includes various FAR clauses regarding small business utilization, minimum wages, and the protection of sensitive government information. Invoicing is to be submitted on a weekly or bi-weekly basis.
Joliet Job Corps

POSTED

about 5 hours ago

DEADLINE

in about 9 hours

General Info

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Rockville, MD, 20852, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts2 people available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate an other than full and open competition basis with GENSCRIPT USA INCORPORATED, 860 CENTENNIAL AVE, PISCATAWAY, NJ, 08854, United States, to procure MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES. The Laboratory of Immunogenetics (LIG) focuses on the cellular and molecular mechanisms that underlie the signaling functions in immune cells. The LIG has recently expanded its focus to include work on developing novel vaccine candidates against different infectious diseases including COVID-19. These monoclonal antibodies and plasmids can be used to design new vaccine candidates and be tested for the ability to prevent the COVID-19 infection. These antibody and plasmid services are necessary to identify and design vaccine candidates against COVID-19. The Antibody Biology Unit (ABU) of the Laboratory of Immunogenetics (LIG), in furtherance of its mission to advance our knowledge of human B cells and isolation of monoclonal antibodies requires a service that provides custom Gene to Antibodies, plasmid heavy chain, and plasmid light chain preparation. These custom antibody and plasmid services can be used to design new vaccine candidates against COVID-19. The ABU has been using GenScript for custom gene to antibody, and this is continuation of a master project that requires some additional work. Continuity is required to retain comparison of results. Requirements List: - SC1946-Ab-CHTP Gene to Antibody-Customized Service:rAb, QTY-178 - CloneArk Plasmid Preparation: rAb HC plasmid, Qty-178 Plasmid Size:0 Starting Material:Prepare at GenScript Copy number:High Template From:Current order:1 Quantity:100.000?g Quality grade:Research Grade (Predominantly supercoiled) Delivery form:Liquid Desired buffer:TE Required concentration:1 mg/ml Aliquot samples: Release Criteria: -CloneArk Plasmid Preparation: rAb LC plasmid, QTY-178 Plasmid Size:0 Starting Material:Prepare at GenScript Copy number:High Template From:Current order:1 Quantity:100.000?g Quality grade:Research Grade (Predominantly supercoiled) Delivery form:Liquid Desired buffer:TE Required concentration:1 mg/ml Aliquot samples: Release Criteria: Period of Performance: 9/20/24-9/19/2025 The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable product/services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-24-2229841) to Angela Puddy at by 12:00 pm EASTERN Standard Time, Wednesday, August 21, 2024. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS